Cargando…

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior

BACKGROUND: A subgroup of patients with fibrotic ILD experience progression and several risk factors for ILD progression have been reported, such as male sex, older age, lower baseline pulmonary function, and a radiological or pathological pattern of usual interstitial pneumonia. OBJECTIVE: To descr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khine, Ngu, Mudawi, Dalia, Rivera-Ortega, Pilar, Leonard, Colm, Chaudhuri, Nazia, Margaritopoulos, George A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2020
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569557/ https://www.ncbi.nlm.nih.gov/pubmed/33093788 http://dx.doi.org/10.36141/svdld.v37i2.9276

Ejemplares similares

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013)

Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis
por: Xiang, Zheyi, et al.
Publicado: (2022)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023)

Comment from the Editor of the Special Issue: “Lung Disease on COPD, Asthma, Bronchiectasis, Lung Cancer Screening, IPF”
por: Chaudhuri, Nazia
Publicado: (2019)

IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe
por: Duck, Annette, et al.
Publicado: (2015)

Highlights of HRCT imaging in IPF
por: Sverzellati, N
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

The role of neutrophils in the pathogenesis of IPF
por: Jegal, Yangjin
Publicado: (2022)

Pirfenidone improves survival in IPF: results from a real-life study
por: Margaritopoulos, George A., et al.
Publicado: (2018)

Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts
por: Schuliga, Michael, et al.
Publicado: (2018)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

The Role of Immunity and Inflammation in IPF Pathogenesis
por: Butler, Marcus W., et al.
Publicado: (2018)

Senescent Cells in IPF: Locked in Repair?
por: Meiners, Silke, et al.
Publicado: (2020)

IPF in Saudi Arabia: Lessons for all
por: Nathan, Steven D.
Publicado: (2020)

Microbiota and IPF: hidden and detected relationships
por: Fabbrizzi, Alessio, et al.
Publicado: (2021)

Radiological and Physiological Predictors of IPF Mortality
por: Kishaba, Tomoo, et al.
Publicado: (2021)

Moving senolytics closer to the clinic in IPF
por: Kramer, Daniel, et al.
Publicado: (2023)

Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF
por: Carobene, Loredana, et al.
Publicado: (2021)

Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)

The Role of Cardiopulmonary Exercise Test in IPF Prognosis
por: Triantafillidou, Christina, et al.
Publicado: (2013)

Opioids: an unexplored option for treatment of dyspnea in IPF
por: Kohberg, Charlotte, et al.
Publicado: (2016)

Evolving Perspectives on Innate Immune Mechanisms of IPF
por: Ishikawa, Genta, et al.
Publicado: (2021)

IPF-Acute Exacerbations: Advances and Future Perspectives
por: Papiris, Spyros A., et al.
Publicado: (2022)

IPF Respiratory Symptoms Management — Current Evidence
por: Janowiak, Piotr, et al.
Publicado: (2022)

Histopathological evaluation of autopsy cases with isolated pulmonary fat embolism (IPFE): is cardiopulmonary resuscitation a main cause of death in IPFE?
por: Turkmen Samdanci, Emine, et al.
Publicado: (2019)

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
por: Tsubouchi, Kazuya, et al.
Publicado: (2023)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Investigation of key autophagy-and mitophagy-related proteins and gene expression in BALF cells from patients with IPF and RA-ILD
por: Vasarmidi, Eirini, et al.
Publicado: (2018)

The pathogenesis of COPD and IPF: Distinct horns of the same devil?
por: Chilosi, Marco, et al.
Publicado: (2012)

Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?
por: Antoniu, Sabina A
Publicado: (2012)

Regulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis
por: Gao, Yulin, et al.
Publicado: (2017)

Imaging Review of the Lung Parenchymal Complications in Patients with IPF
por: Baratella, Elisa, et al.
Publicado: (2019)

Diffuse alveolar hemorrhage complicating acute exacerbation of IPF
por: Murohashi, Kota, et al.
Publicado: (2020)

Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis
por: Bloem, Ada E. M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8rkpvd46u2jb6mj8fithp56mme